Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CATB | AMGN | BMY | VRTX | REGN |
Company | Catabasis Pharma | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 9.21 | 269.18 | 45.09 | 397.48 | 883.20 |
High | 9.21 | 273.71 | 45.38 | 399.31 | 896.92 |
Low | 8.46 | 268.99 | 45.08 | 397.09 | 883.20 |
Last | 8.54 | 274.24 | 45.11 | 397.78 | 895.14 |
Change | -0.64 | +4.26 | +0.26 | +0.30 | +11.94 |
% Change | -6.97% | +1.58% | +0.58% | +0.08% | +1.35% |
Volume | 98,800 | 78,611 | 775,972 | 53,719 | 15,554 |
20-Day Average Volume | 395,311 | 2,064,365 | 12,756,418 | 906,722 | 439,278 |
Previous Close | 9.18 | 269.98 | 44.85 | 397.48 | 883.20 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 8.72 | 269.51 | 49.09 | 400.15 | 914.81 |
20-Day Raw Stochastic | 56.46% | 55.06% | 11.04% | 22.97% | 22.33% |
20-Day Relative Strength | 43.24% | 49.22% | 31.86% | 42.91% | 38.40% |
Weighted Alpha | -50.43 | +12.35 | -33.97 | +13.09 | +15.58 |
Today's Opinion | 88% Sell | 40% Sell | 88% Sell | 8% Sell | 8% Buy |
Previous Opinion | 72% Sell | 72% Sell | 88% Sell | 8% Buy | 8% Sell |
Last Month's Opinion | 100% Sell | 24% Buy | 24% Buy | 56% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -14.34% since 08/31/21 | +0.57% since 04/22/24 | -7.74% since 04/22/24 | -0.51% since 04/22/24 | -0.61% since 04/22/24 |
Low | 8.46 on 09/08/21 | 265.72 on 04/26/24 | 44.34 on 04/26/24 | 393.00 on 04/25/24 | 875.22 on 04/26/24 |
High | 10.26 on 09/02/21 | 274.86 on 04/24/24 | 49.47 on 04/23/24 | 406.86 on 04/23/24 | 915.70 on 04/24/24 |
1-Month | |||||
%Chg | -8.17% since 08/06/21 | -3.82% since 03/28/24 | -16.40% since 03/28/24 | -4.82% since 03/28/24 | -7.05% since 03/28/24 |
Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
High | 10.26 on 09/02/21 | 283.91 on 04/02/24 | 54.23 on 04/01/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 |
3-Month | |||||
%Chg | -34.10% since 06/08/21 | -12.75% since 01/29/24 | -9.09% since 01/29/24 | -8.71% since 01/29/24 | -6.40% since 01/29/24 |
Low | 6.31 on 08/20/21 | 260.68 on 04/19/24 | 44.34 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
High | 15.72 on 06/16/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -50.23% since 03/08/21 | +4.55% since 10/27/23 | -11.14% since 10/27/23 | +11.99% since 10/27/23 | +15.41% since 10/27/23 |
Low | 6.31 on 08/20/21 | 249.70 on 10/31/23 | 44.34 on 04/26/24 | 341.90 on 11/16/23 | 772.84 on 10/31/23 |
High | 22.01 on 03/18/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 33,337 | 144,810,784 | 90,900,144 | 102,732,288 | 96,941,800 |
Shares Outstanding, K | 3,904 | 536,376 | 2,026,759 | 258,459 | 109,762 |
Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 13,117,200,000 |
Annual Net Income | -37,300,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 3,953,600,000 |
Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 2,517,700,000 | 3,434,300,000 |
Last Quarter Net Income | -7,470,000 | 767,000,000 | 1,762,000,000 | 968,800,000 | 1,159,600,000 |
60-Month Beta | 1.66 | 0.58 | 0.39 | 0.35 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 4.71 on 02/06/24 | -4.40 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 08/09/21 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.44 | 6.08 | 29.59 | 23.70 |